Mather Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Sell |
3,143
-110
| -3% | -$7.69K | ﹤0.01% | 579 |
|
|
2025
Q1 | $239K | Buy |
3,253
+268
| +9% | +$19.7K | ﹤0.01% | 540 |
|
|
2024
Q4 | $196K | Sell |
2,985
-103
| -3% | -$6.75K | ﹤0.01% | 574 |
|
|
2024
Q3 | $241K | Sell |
3,088
-701
| -19% | -$54.6K | ﹤0.01% | 519 |
|
|
2024
Q2 | $257K | Buy |
3,789
+708
| +23% | +$48K | ﹤0.01% | 565 |
|
|
2024
Q1 | $208K | Buy |
+3,081
| New | +$208K | ﹤0.01% | 518 |
|
|
2023
Q2 | – | Sell |
-2,888
| Closed | -$200K | – | 621 |
|
|
2023
Q1 | $200K | Buy |
+2,888
| New | +$200K | ﹤0.01% | 500 |
|
|
2022
Q3 | – | Sell |
-3,158
| Closed | -$209K | – | 470 |
|
|
2022
Q2 | $209K | Hold |
3,158
| – | – | ﹤0.01% | 359 |
|
|
2022
Q1 | $209K | Buy |
+3,158
| New | +$209K | ﹤0.01% | 426 |
|
|
2020
Q1 | – | Sell |
-5,338
| Closed | -$266K | – | 139 |
|
|
2019
Q4 | $266K | Buy |
+5,338
| New | +$266K | 0.02% | 140 |
|